Skip to content
Disclosery

Healthcare Value Capital, LLC

Follow

13F filer, CIK 1458461, Woodcliff Lake, NJ

Healthcare Value Capital, LLC reported $29,681,000 across 17 holdings for the quarter ended 2020-12-31, in a 13F-HR filed 2021-02-16. Its ten largest share positions make up 92.89% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000919574-21-001429

Period
2020-12-31
Reported value
$29.7M
Holdings
17
Top 10 weight
92.89%
New
1
Sold out
2

Largest buys vs the previous quarter

SecurityShares changeApprox. value
GAMIDA CELL LTDnew+50,000$420K
VYNE THERAPEUTICS INCadded+200,000$316K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
JAZZreduced-15,000-$2.48M
INVESCO QQQ TRUST SERIES 1exited-250,000-$2.17M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2020

Share positions as resolved from 13F-HR 0000919574-21-001429, largest first. % of portfolio is the value over $25,924,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
ABBVABBVIE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: 50,000 shares; 2020Q1: 50,000 shares; 2020Q2: 25,000 shares; 2020Q3: 35,000 shares; 2020Q4: 35,000 shares 35,000$3.75M14.47%0Timeline
GLAXOSMITHKLINE PLC-ADRGLAXOSMITHKLINE PLC-ADRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: 100,000 shares; 2020Q1: 100,000 shares; 2020Q2: 100,000 shares; 2020Q3: 100,000 shares; 2020Q4: 100,000 shares 100,000$3.68M14.2%0
VYNE THERAPEUTICS INCVYNE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: not reported; 2020Q1: not reported; 2020Q2: not reported; 2020Q3: 1,800,000 shares; 2020Q4: 2,000,000 shares 2,000,000$3.16M12.19%+200,000
GILDGILEAD SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: 70,000 shares; 2020Q1: 50,000 shares; 2020Q2: 50,000 shares; 2020Q3: 50,000 shares; 2020Q4: 50,000 shares 50,000$2.91M11.24%0Timeline
TYME TECHNOLOGIES INC COMTYME TECHNOLOGIES INC COMQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: 2,175,000 shares; 2020Q1: 2,175,000 shares; 2020Q2: 2,175,000 shares; 2020Q3: 2,175,000 shares; 2020Q4: 2,175,000 shares 2,175,000$2.65M10.24%0
ANTARES PHARMA INCANTARES PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: 300,000 shares; 2020Q1: 500,000 shares; 2020Q2: 500,000 shares; 2020Q3: 500,000 shares; 2020Q4: 500,000 shares 500,000$2M7.7%0
MCKMCKESSON CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: 10,000 shares; 2020Q1: 25,000 shares; 2020Q2: 10,000 shares; 2020Q3: 10,000 shares; 2020Q4: 10,000 shares 10,000$1.74M6.71%0Timeline
JAZZJAZZ PHARMACEUTICALS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: not reported; 2020Q1: 30,000 shares; 2020Q2: 19,000 shares; 2020Q3: 25,000 shares; 2020Q4: 10,000 shares 10,000$1.65M6.37%-15,000Timeline
CAHCARDINAL HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: 35,000 shares; 2020Q1: 75,000 shares; 2020Q2: 50,000 shares; 2020Q3: 25,000 shares; 2020Q4: 25,000 shares 25,000$1.34M5.17%0Timeline
CLOVIS ONCOLOGY INCCLOVIS ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: 150,000 shares; 2020Q1: 250,000 shares; 2020Q2: 250,000 shares; 2020Q3: 250,000 shares; 2020Q4: 250,000 shares 250,000$1.2M4.63%0
GREENLANE HLDGS INCGREENLANE HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: 175,000 shares; 2020Q1: 225,000 shares; 2020Q2: 250,000 shares; 2020Q3: 250,000 shares; 2020Q4: 250,000 shares 250,000$990K3.82%0
ADAMAS PHARMACEUTICALS INCADAMAS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: not reported; 2020Q1: not reported; 2020Q2: not reported; 2020Q3: 100,000 shares; 2020Q4: 100,000 shares 100,000$433K1.67%0
GAMIDA CELL LTDGAMIDA CELL LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: not reported; 2020Q1: not reported; 2020Q2: not reported; 2020Q3: not reported; 2020Q4: 50,000 shares 50,000$420K1.62%new

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
AMARIN CORP PLCAMARIN CORP PLC SPONS ADR NEWcall300,000$1.47M+200,000
MRNAMODERNA INC COMput10,000$1.04M0
Proshares VIX Short-TermProshares VIX Short-Term Equitycall50,000$687K+25,000
NVAXNOVAVAX INC COM NEWput5,000$558K0

Sold out in Q4 2020

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
INVESCO QQQ TRUST SERIES 1INVESCO QQQ TRUST SERIES 1250,000$2.17Mshares
INVESCO QQQ TRUST SERIES 1INVESCO QQQ TRUST SERIES 1100,000$870Kcall

How Q4 2020 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000919574-21-001429 base2021-02-16acceptance time not in the bulk data set